Toray Industries, Inc. - Product Pipeline Review - 2016

Published: Oct, 2016 | Pages: 43 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Toray Industries, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Toray Industries, Inc. - Product Pipeline Review - 2016', provides an overview of the Toray Industries, Inc.'s pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Toray Industries, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Toray Industries, Inc.
- The report provides overview of Toray Industries, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Toray Industries, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Toray Industries, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Toray Industries, Inc.'s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Toray Industries, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Toray Industries, Inc.'s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Toray Industries, Inc. Snapshot 5
Toray Industries, Inc. Overview 5
Key Facts 5
Toray Industries, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Toray Industries, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Toray Industries, Inc. - Pipeline Products Glance 14
Toray Industries, Inc. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Toray Industries, Inc. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Toray Industries, Inc. - Drug Profiles 17
beraprost sodium ER - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
GT-0198 - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
HIS-388 - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Small Molecule to Agonize Prostacyclin Receptor for Bleeding and Clotting Disorders - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Small Molecule to Antagonize Alpha1B Adrenoceptor - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Small Molecule to Antagonize CCR3 for Undisclosed Indication - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Small Molecule to Block TRPV1 for Overactive Bladder - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
Small Molecule to Inhibit Soluble Epoxide Hydrolase for Chronic Kidney Disease - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
Small Molecules to Antagonize mGluR5 for Anxiety - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
Small Molecules to Inhibit Dipeptidyl Peptidase IV for Type 2 Diabetes - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
Small Molecules to Inhibit Soluble Epoxide Hydrolase for Pulmonary Arterial Hypertension - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
TRK-390 - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
TRK-700 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
Toray Industries, Inc. - Pipeline Analysis 30
Toray Industries, Inc. - Pipeline Products by Target 30
Toray Industries, Inc. - Pipeline Products by Route of Administration 31
Toray Industries, Inc. - Pipeline Products by Molecule Type 32
Toray Industries, Inc. - Pipeline Products by Mechanism of Action 33
Toray Industries, Inc. - Dormant Projects 34
Toray Industries, Inc. - Discontinued Pipeline Products 35
Discontinued Pipeline Product Profiles 35
beraprost sodium SR 35
TAK-363 35
Toray Industries, Inc. - Company Statement 36
Toray Industries, Inc. - Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Appendix 42
Methodology 42
Coverage 42
Secondary Research 42
Primary Research 42
Expert Panel Validation 42
Contact Us 42
Disclaimer 43

List of Tables

Toray Industries, Inc., Key Facts 5
Toray Industries, Inc. - Pipeline by Indication, 2016 7
Toray Industries, Inc. - Pipeline by Stage of Development, 2016 8
Toray Industries, Inc. - Monotherapy Products in Pipeline, 2016 9
Toray Industries, Inc. - Partnered Products in Pipeline, 2016 10
Toray Industries, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 11
Toray Industries, Inc. - Out-Licensed Products in Pipeline, 2016 12
Toray Industries, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 13
Toray Industries, Inc. - Phase II, 2016 14
Toray Industries, Inc. - Preclinical, 2016 15
Toray Industries, Inc. - Discovery, 2016 16
Toray Industries, Inc. - Pipeline by Target, 2016 30
Toray Industries, Inc. - Pipeline by Route of Administration, 2016 31
Toray Industries, Inc. - Pipeline by Molecule Type, 2016 32
Toray Industries, Inc. - Pipeline Products by Mechanism of Action, 2016 33
Toray Industries, Inc. - Dormant Developmental Projects,2016 34
Toray Industries, Inc. - Discontinued Pipeline Products, 2016 35
Toray Industries, Inc., Other Locations 37
Toray Industries, Inc., Subsidiaries 38